跳至主要内容
临床试验/DRKS00026187
DRKS00026187已完成不适用

The collection of spine and pelvis specific movement parameters during gait of competitive athletes using videorasterstereography

niversitätsmedizin MainzZentrum für Orthopädie und Unfallchirurgie0 个研究点目标入组 40 人开始时间: 2021年10月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 30 Years(—)
性别
All

入选标准

  • 1. subjects of both biological sexes between 18 and 30 years.
  • 2. test persons who have been practicing competitive sports for a total of at least 12 months with a training frequency of 5 units per week for at least 1 hour each. Training breaks, such as vacation days or injury breaks, do not count.
  • 3. 50 % of the test persons should only participate in sports that include running as an important component, such as long-distance runners, sprinters, or soccer players.
  • 4. 50 % of the test persons can participate in different sports in which running is required for the exercise of the discipline.

排除标准

  • 1. subjects who have received surgical treatment to the musculoskeletal system in the last 6 months or have had an injury that resulted in a training break of > 3 weeks.
  • 2. subjects who have suffered from musculoskeletal complaints (including back pain) requiring treatment in the last 6 weeks, resulting in consultation with a physician and who have been treated with prescription drugs, physiotherapy, osteopathy, or other remedies.
  • 3. subjects who report pain while walking on the agreed examination date, which is of intensity > 0 on the Numerical Rating Scale (NRS).
  • 4. subjects who have had spinal surgery (nucleotomy, spondylodesis, etc.) and/or pelvic surgery in their past life, or have had severe pelvic and/or back disease/injury (discectomy, vertebral fracture, pelvic fracture, etc.).
  • 5. subjects who participate in disability sports.
  • 6. subjects whose walking speed and resulting walking distance are limited. Verification will be done in the context of a 2-minute walking test. There will be
  • a. female subjects excluded from study participation if the achieved walking distance after 2 minutes is <180.8m.
  • b. male subjects excluded from study participation if the achieved walking distance after 2 minutes is <197.2m.
  • 7. subjects whose large joints of the lower and upper extremities have limitations in active range of motion. Range of motion will be assessed with a goniometer using the neutral zero method. Subjects will be excluded from study participation if, in the upright standing position (data in degrees):
  • a. Hip extension/flexion: =20/0/25.
  • b. Hip abduction/adduction: =5/0/10.
  • c. Hip internal rotation/external rotation: =5/0/10.
  • d. Knee extension/flexion: =0/0/60
  • e. OSG dorsiflexion/plantarflexion: =10/0/15.
  • f. Shoulder extension/flexion: =20/0/25
  • g. Elbow extension/flexion: =0/20/45.
  • 8. subjects whose spinal mobility is limited. Range of motion will be verified through the use of a plurimeter. Subjects will be excluded from study participation if
  • a. ROM in the frontal plane re/li: =10/0/10.
  • b. ROM in the transverse plane re/li: =10/0/10.
  • 9. subjects who take >12 seconds to complete the timed-up-and-go test (TUG) on the agreed examination date.
  • 10. subjects who achieve a test score of = 2 points on the Back Performance Scale (BPS) test administration.
  • 11. subjects who have back contour changes due to large scars, tumors, or due to tattoos in the measurement area.
  • 12. subjects who have a BMI > 30 kg/m² on the agreed examination date.
  • 13. subjects who have taken painkillers on the agreed examination date.
  • 14. subjects suffering from cold symptoms (cough, fever, etc.) on the agreed examination date, have a confirmed COVID-19 disease.
  • 15. subjects who have had a deliberate contact with a positively tested COVID-19 patient or have been in a risk area declared by the Robert Koch Institute in the two weeks prior on the agreed examination date.
  • 16. subjects suffering from an acute medical condition, such as dizziness, nausea, balance disorders, or injury, on the day of the agreed examination date.
  • 17. subjects who are not fully capable of consent or understanding on the agreed examination date.
  • 18. subjects who are pregnant on the agreed examination date.
  • 19. subjects who suffer from fluctuating disease processes (e.g. multiple sclerosis).

研究者

发起方
niversitätsmedizin MainzZentrum für Orthopädie und Unfallchirurgie

相似试验